Thoroughbred Financial Services, LLC Organon & Co. Transaction History

Thoroughbred Financial Services, LLC

  • $1.55 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022
SELL
$23.4 - $34.25 $98,420 - $144,055
-4,206 Reduced 23.37%
13,790 $322,000
Q2 2022

Aug 03, 2022
BUY
$31.66 - $38.9 $146,617 - $180,145
4,631 Added 34.65%
17,996 $607,000
Q1 2022

May 04, 2022
BUY
$30.45 - $39.36 $406,964 - $526,046
13,365 New
13,365 $466,000

Others Institutions Holding OGN

# of Institutions
794
Shares Held
193M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.11B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email